戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                 She denied having a fever or night sweats.
2 inal dryness but no significant reduction in night sweats.
3 temperature of 38.8 degrees C, and drenching night sweats.
4 opausal symptoms (VMSs), ie, hot flushes and night sweats.
5 gulatory mechanisms leads to hot flushes and night sweats.
6  power of hot flashes for any symptom except night sweats.
7  TB symptoms (cough, fever, weight loss, and night sweats; 1 point each), and >14-day symptom duratio
8 sed, and the patient had begun to experience night sweats and fevers.
9 ed reported vasomotor symptoms (hot flashes, night sweats) and serum levels of follicle-stimulating h
10 mphadenopathy, progressive dyspnea, fatigue, night sweats, and an unintentional weight loss of 25 pou
11                        Fever, myalgia, rash, night sweats, and arthralgia occurred more frequently in
12  antigen positivity identified recent fever, night sweats, and arthralgias as symptoms that may be pr
13 moptysis, fever, chronic cough, weight loss, night sweats, and poor appetite).
14 ng symptoms, including weight loss, fatigue, night sweats, and pruritus, had rapid improvement.
15 nced a two-week episode of fever, headaches, night sweats, and rapid weight loss of 10 kg.
16                                 Hot flashes, night sweats, and vaginal dryness.
17 ytopenia and/or symptoms of fever, drenching night sweats, and weight loss (B symptoms) should be off
18 tuberculosis (coughing for at least 2 weeks, night sweats, and weight loss) were enrolled at China-Ug
19 ion (WHO) 4-symptom screening (fever, cough, night sweats, and weight loss), a rapid test detecting m
20 rated, could control type B symptoms (fever, night sweats, and weight loss), and had antitumor activi
21  dysfunction, presence of B symptoms (fever, night sweats, and weight loss), and multi-organ involvem
22  and/or systemic B symptoms including fever, night sweats, and/or weight loss (P =.05).
23 rted cough [aOR 4.62 (3.42, 6.27)], reported night sweats [aOR 1.50 (1.21, 1.90)], and having HIV inf
24          Vasomotor symptoms (hot flushes and night sweats) are experienced by more than two-thirds of
25 ys' duration, along with nausea, chills, and night sweats, but no respiratory symptoms, on the day of
26  symptoms (cough, weight loss for >=4 weeks, night sweats, chest pain, and fever for >=2 weeks), or c
27                   The patient denied fevers, night sweats, contact with sick individuals, occupationa
28 luded transient hypotension, fever, fatigue, night sweats, diarrhea, nausea, vomiting, hypokalemia, a
29 hough the hallmark symptoms are hot flashes, night sweats, disrupted sleep, and genitourinary discomf
30 omen report vasomotor symptoms (hot flashes, night sweats) during midlife, their etiology and risk fa
31 nia (adds either cough, sputum, fever/chills/night sweats, dyspnea or pleuritic chest pain) or with P
32 reduction in splenomegaly and alleviation of night sweats, fatigue, and pruritus.
33 han half of the patients with early satiety, night sweats, fatigue, pruritus, and cough achieved rapi
34 ose with >=1 TB symptom (cough, weight loss, night sweats, fever) or abnormal chest radiograph were a
35 oman, was seen with urticaria and associated night sweats, fevers, and polyarticular arthritis.
36 rade 3 or higher were fatigue (five vs one), night sweats (four vs one), and anaemia (one vs three).
37                   She had no fevers, chills, night sweats, hemoptysis, wheezing, chest pain, palpitat
38 , on the perceived impact of hot flushes and night sweats (HF/NS) and overall levels of menopausal sy
39                              Hot flushes and night sweats (HFNS) affect 65-85% of women after breast
40 ificant medical history experienced fatigue, night sweats, hoarseness of voice, and dry cough, which
41  jaw pain, anorexia, lethargy, weakness, and night sweats; imaging revealed generalized lymphadenopat
42 est as menstrual abnormalities, hot flashes, night sweats, impaired fertility, and in the long term,
43  was reported in 52%, weight loss in 57% and night sweats in 48% of patients.
44  in 52% of patients, weight loss in 57%, and night sweats in 48%.
45              Short-term adverse events-acne, night sweats, increased weight, and altered mood and lib
46 atory dysfunction, including hot flushes and night sweats, is effectively treated by hormonal therapi
47 e, concentration, early satiety, inactivity, night sweats, itching, bone pain, abdominal discomfort,
48 h of any duration, fever of any duration, or night sweats lasting 3 or more weeks in the preceding 4
49 ptoms of hot flashes (LR+ range, 2.15-4.06), night sweats (LR+ 1.90; 95% confidence interval [CI], 1.
50 Score of moderate and severe hot flushes and night sweats (msVMS-SS) between Q-122 and placebo after
51 or all symptoms, particularly hot flashes or night sweats (odds ratios = 2.06-4.32), were for women w
52  loss >=1.5 kg in the last month, or current night sweats) or that a household member was currently o
53 mately 50% to 75% of women have hot flashes, night sweats, or both (vasomotor symptoms) and more than
54 onths but denied experiencing fever, chills, night sweats, or gastrointestinal, musculoskeletal, or n
55                     He did not report fever, night sweats, or hemoptysis.
56 sis identified recurrent undiagnosed fevers, night sweats, oropharyngeal thrush, and unintentional we
57 he treatment groups but not in the number of night sweats (pooled mean difference of changes, -2.14 [
58 e in the perceived burden of hot flashes and night sweats (problem rating scale of the Hot Flush Rati
59 ignificant symptoms were weight loss, fever, night sweats, productive cough and haemoptysis.
60 ng constitutional symptoms such as drenching night sweats, profound fatigue, unexplained fevers, and
61  or anemia and no symptoms of early satiety, night sweats, pruritus, or erythromelalgia.
62 ined weight loss, abdominal pain, fever, and night sweating should alert physicians to this complicat
63 ce of current cough, fever, weight loss, and night sweats should be used to identify eligible pregnan
64                               Hot flashes or night sweats, urine leakage, and stiffness or soreness w
65 l symptoms can extend beyond hot flushes and night sweats (vasomotor symptoms).
66  an inflammatory phenotype, including fever, night sweats, weight loss, and skin rash.
67   The relations between body fat changes and night sweats were not statistically significant.
68                                              Night sweats were reported by 9% of the p24 antigenemic,
69           Overall, fever, joint pain, and/or night sweats were reported in 27 (47%) of the 58 subject
70 otor symptoms (hot flashes, cold sweats, and night sweats) were reduced by approximately 50% in the 2
71               VMS, including hot flushes and night sweats, were assessed using the Korean version of
72              VMSs, including hot flashes and night sweats, were assessed using the Menopause-Specific
73  with tuberculosis may cause weight loss and night sweats, yet in animal models it has a protective r